Tiny Deciphera will hustle optimistic PhIII survival information on lead cancer drug to the FDA in search of its very first OK — shares soar – Endpoints News


Overall health insurer Humana has had sufficient of Mallinckrodt, and the drugmaker’s highly-priced, controversial remedy Acthar gel, which was very first authorized for a broad variety of circumstances by the FDA back in 1952.

Extracted from the pituitary glands of slaughtered pigs, the drug is a purified preparation of adrenocorticotropic hormone (ACTH) — and is manufactured primarily the identical way as it was when it was very first found in the late 1940s by the meat firm Armour, as a byproduct of pork-processing operations.

Having said that, its cost has catapulted from $40 per vial in 2001 to a whopping $38,892 as of this July. “This is a 97,500% cost improve. It is as if the cost of milk elevated from $three to more than $two,900 per gallon, or a mortgage payment rose from $two,000 to more than $two million per month,” Humana $HUM stated in a lawsuit filed against Mallinckrodt $MNK final week.

Endpoints News

Fundamental subscription necessary

Unlock this story immediately and join 56,900+ biopharma pros reading Endpoints every day — and it really is totally free.



Latest posts